中文

← All funding rounds

Big Picture Bio

EuropeDrug discoveryLondon, United KingdomPrivate

Designs cancer drug combinations, and their order, with a generative model of how tumours, immune cells and surrounding tissue interact across disease sites and patient groups, then tests the picks in its own wet-lab work; it starts with cancer and immune-mediated diseases.

Disclosed total£1.5M≈ $2.01M · in USD at each round's date
Rounds on record1
Latest round£1.5MPre-seed · 2026-09-17
Last stated valuationNone stated
Investors named4
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date≈$2.01M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-09-17Pre-seed
    Round

    £1.5M≈ $2.01M

    For: take its first designed drug combinations from in silico design into wet-lab validation

    Wet lab

    John White is an angel investor. The release adds £700K of non-dilutive Innovate UK funding through its Investor Partnerships Programme, for £2.2M in all; that grant is not counted here.

    Co-lead · Kadmos CapitalCo-lead · Exceptional VenturesGloucester VenturesJohn White

    On the deal: Paolo Pio (Co-Founder and General Partner; spoke for the co-lead in the announcement, Exceptional Ventures); Remy Kesrouani (Managing Partner; spoke for the co-lead in the announcement, Kadmos Capital)

    Announced by the company · cambridgenetwork.co.uk ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →